Dr Reddy’s completes clinical studies of rituximab biosimilar for filing in US and Europe
Dr Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.